Acacia Pharma Agrees To Be Bought By Eagle Pharma In €94.7 Mln Cash, Stock Deal

Acacia Pharma Group Plc (ACPH.BR) announced Monday its agreement to be acquired by Eagle Pharmaceuticals, Inc. (EGRX) by way of a scheme of arrangement in around 94.7 million euros cash and stock deal.

The total consideration equates to 0.90 euro for each Scheme Share. Under the terms of the proposed scheme of arrangement, each Scheme Shareholder will receive 0.68 euro in cash and 0.0049 New Eagle Shares. The cash portion of the deal represents approximately 75 percent of the total price, and the shares represent the remaining 25 percent.

The Acacia Directors consider the proposed transaction to be the best available option for Acacia Shareholders and intend unanimously to recommend that shareholders vote in favour of the Scheme.

Eagle has received irrevocable undertakings representing approximately 48.78 percent of the issued share capital of Acacia.

The Scheme is expected to become effective between the middle of May 2022 and 30 June 2022, subject to the satisfaction of the terms.

The agreement follows a comprehensive review and assessment of all strategic alternatives, including consideration of options to raise additional capital.

Acacia noted that it met its formulary goals for both Barhemsys and Byfavo in fiscal 2021 and sees significant future commercial potential for the products.

However, the company's standalone financial condition has been negatively impacted by physical access limitations caused by the global COVID-19 pandemic, and a significant latency of demand due to postponement of surgical procedures.

Accordingly, Acacia expects it would require a minimum of around $115 million of additional cash to fund operations to break-even, based on projections assuming break-even by early fiscal 2025.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. may face production shortfall of as many as 6 million iPhone Pro units this year due to ongoing protests at its major China plant, Bloomberg reported citing a person familiar with assembly operations. Following the news, Apple shares were losing around 2.2 percent in pre-market activity on the Nasdaq. Despite fears of inflation, consumers spent $9.12 billion for online shopping during Black Friday, higher than in previous years, as per a report published by Adobe Analytics. During the 2022 holiday season, total estimated revenues are $209.7 billion, a growth of 2.5 percent from last year's recorded revenues of $205 billion. Weis Markets, Inc., a Mid Atlantic food retailer, has recalled 108 containers of Weis Quality Sea Salt Caramel Ripple Ice Cream citing possible presence of undeclared soy and coconut allergens, the U.S. Food and Drug Administration said. The recalled product comes in 48oz containers that says Weis Quality Sea Salt Caramel Ripple Ice Cream, while the lid says Weis Quality Caramel Caribou Ice Cream
Follow RTT